EnBio Holdings, Inc
株式会社エンバイオ・ホールディングス
Valuation
Fundamental ratios for the latest reported period.
Ticker: 6092
FY2025 (Mar 2026) · J-GAAP · consolidated Source: filing S100YKUO
FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2025 (Mar 2026) runs Apr 1, 2025 – Mar 31, 2026.
| Gross margin | 29.2% |
|---|---|
| Operating margin | 12.8% |
| Net margin | 2.1% |
| Return on equity | 2.9%Includes one-off items (e.g. gains on negative goodwill) |
| Return on assets | 1.2% |
| Revenue growth (YoY) | 18.4% |
| EPS (basic) | ¥32.73 |
| EPS growth (YoY) | -41.4% |
| Current ratio | 2.20x |
| Equity ratio | 40.5% |
| Book value / share | ¥1,139.31 |
| Free cash flow | ¥114M |